Let me share something that really made me pause when I read about it recently.
There's a genetic disorder called Phelan-McDermid syndrome (try saying that three times fast!). For years, it's been considered extremely rare — the kind of thing that affects maybe 1 in 50,000 to 1 in 100,000 people. But here's the thing: new research suggests those numbers might be way off.
A team at Mount Sinai just published findings estimating that this condition actually affects roughly 1 in 7,300 people. That's a massive jump. In the United States alone, that could mean over 45,000 individuals walking around with this syndrome without even knowing it.
So what is Phelan-McDermid syndrome, and why should you care?
The Short Version
It all comes down to a problem with a gene called SHANK3, which sits on chromosome 22. When this gene is deleted or mutated, it can lead to a whole spectrum of challenges — everything from intellectual disabilities to speech delays to features we commonly see in autism. In fact, most people with this syndrome actually meet the criteria for an autism diagnosis. Changes in SHANK3 are believed to account for about 1% of all autism cases, which sounds small until you realize there are millions of autistic people worldwide.
Why Are So Many Cases Going Undiagnosed?
This is where it gets frustrating.
The researchers looked at data from nearly 180,000 people with autism who had genetic testing. After crunching the numbers and accounting for various factors, they concluded that the real prevalence is much higher than what we've been seeing clinically.
The lead researcher, Tess Levy, put it this way: many individuals with developmental disabilities and autism are simply never offered genetic testing in the first place. Insurance barriers exist. Some tests aren't comprehensive enough to catch the SHANK3 changes. And even when testing happens, connecting the dots to Phelan-McDermid syndrome requires specialized knowledge.
Basically, there are probably thousands of families out there who have been searching for answers — who've been told "we don't know what's causing this" — when the explanation might have been hiding in their child's genes all along.
Why Does Getting a Diagnosis Matter?
Great question. And honestly, this is where things get exciting.
For a long time, knowing you had Phelan-McDermid syndrome was mostly about understanding why certain challenges existed. It provided closure, maybe, but not much in the way of solutions.
That's changing fast. Multiple clinical trials are now targeting the biology of this condition specifically. We're talking about precision medicine approaches — treatments designed to address the actual genetic cause, not just the symptoms. One organization, Neuren Pharmaceuticals, is even working on drug candidates that could modify the course of the disorder.
As Joseph Buxbaum, one of the study's senior authors, put it: "Knowledge is power." Getting a genetic diagnosis can open doors to specialized care, research studies, clinical trials, support networks, and potentially treatments that could genuinely improve quality of life.
The Bottom Line
This research is a call to action, really. If you have a child with autism, or if you work with families who do, genetic testing isn't just a box to check — it could be the key to understanding something fundamental about what's going on.
And if you're someone who's been searching for answers about developmental delays, intellectual disabilities, or autism without ever getting a clear explanation? This might be worth asking your doctor about.
We're living in an incredible era of genetic medicine. Every day, scientists are discovering more about how our DNA shapes our health — and more importantly, how we might be able to intervene. Phelan-McDermid syndrome is a perfect example: what was once considered vanishingly rare is turning out to be much more common, and the hope on the horizon has never been brighter.
Sometimes the answer has been written in our genes all along. We just need to look.
Sources & Further Reading:
- Original research published in Autism Research (Mount Sinai / Seaver Autism Center)
- https://www.sciencedaily.com/releases/2026/09/260924020405.htm